Myelofibrosis Plasma | High-Quality Human Plasma from Myelofibrosis Donors

Myelofibrosis Plasma is collected from donors clinically diagnosed with myelofibrosis and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research in cytokines, growth factors, and circulating tumor DNA (ctDNA) in myelofibrosis pathogenesis.

Product Features

• Research Use Only (RUO)
• Plasma collected from clinically confirmed myelofibrosis donors
• Processed within one day of collection
• IRB-approved protocols and informed consent
• Custom aliquot volumes available upon request

Donor Metadata

• Verified myelofibrosis diagnosis
• Demographic data: age, sex assigned at birth, race/ethnicity
• Donor-reported medications, allergies, and comorbidities
• Additional myelofibrosis-specific metadata available

Applications

• Biomarker discovery and validation
• Cytokine and inflammation profiling
• Metabolomics and proteomics studies
• Therapeutic response research

Compliance and Quality Assurance

• IRB-approved and HIPAA-compliant protocols
• Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
• Documentation support available for regulatory review

Ordering and Customization

Myelofibrosis plasma is available in standard and custom volumes. For international orders or documentation requirements, please email to ensure compatibility with your country’s regulations.